Publications by authors named "Maria Rosa Cappelletti"

30Publications

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit.

Br J Cancer 2018 12 27;119(12):1487-1494. Epub 2018 Nov 27.

Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.

View Article and Find Full Text PDF
December 2018

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer.

Onco Targets Ther 2017 31;10:3811-3815. Epub 2017 Jul 31.

Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

View Article and Find Full Text PDF
July 2017

CDK4/6 inhibitors in HER2-positive breast cancer.

Crit Rev Oncol Hematol 2017 Apr 24;112:208-214. Epub 2017 Feb 24.

Azienda Ospedaliera di Cremona, U.O. Multidisciplinare di Patologia Mammaria, U.S. Terapia Molecolare e Farmacogenomica, Cremona, Italy; Universita degli Studi di Trieste, Department of Medical, Surgery and Health Sciences, Trieste, Italy.

View Article and Find Full Text PDF
April 2017

New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials.

Crit Rev Oncol Hematol 2016 Dec 29;108:62-68. Epub 2016 Oct 29.

Unit of Molecular Therapy and Pharmacogenomic, ASST Cremona, Viale Concordia 1, 26100 Cremona, Italy; Department of Medical, Surgery and Health Sciences, University of Trieste, Piazza Ospitale 1, 34129 Trieste, Italy.

View Article and Find Full Text PDF
December 2016

Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials.

Medicine (Baltimore) 2016 Oct;95(43):e4636

Section of Pharmacology and University Center DIFF-Drug Innovation Forward Future, Department of Molecular and Translational Medicine, University of Brescia, Brescia U.S. Terapia Molecolare e Farmacogenomica Radiotherapy Department, ASST Cremona, Cremona Section of Experimental Oncology, Department of Clinical and Experimental Medicine, University of Parma, Parma Unit of General Medicine, Azienda Ospedaliera "C. Poma" Presidio Ospedaliero di Pieve di Coriano, Mantova Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

View Article and Find Full Text PDF
October 2016

Apatinib for the treatment of gastric cancer.

Expert Rev Gastroenterol Hepatol 2016 Aug 15;10(8):887-92. Epub 2016 Jul 15.

b Unit of Molecular Therapy and Pharmacogenomic , ASST Cremona , Cremona , Italy.

View Article and Find Full Text PDF
August 2016

No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials.

Clin Lung Cancer 2016 09 2;17(5):334-340. Epub 2016 Jun 2.

US Terapia Molecolare e Farmacogenomica, Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

View Article and Find Full Text PDF
September 2016

Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials.

Eur J Cancer 2016 07 7;61:111-21. Epub 2016 May 7.

Molecular Therapy and Pharmacogenomic Unit, ASST di Cremona, Viale Concordia 1, 26100, Cremona, Italy; Department of Medical, Surgery and Health Sciences, University of Trieste, Piazza Ospitale 1, 34129, Trieste, Italy.

View Article and Find Full Text PDF
July 2016

Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials.

Crit Rev Oncol Hematol 2016 May 27;101:12-20. Epub 2016 Feb 27.

Unit of molecular therapy and pharmacogenomic, AO Azienda Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100 Cremona, Italy; Department of Medical, Surgery and Health Sciences, University of Trieste, Piazza Ospitale 1, 34129 Trieste, Italy.

View Article and Find Full Text PDF
May 2016

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

Tumour Biol 2015 Sep 26;36(9):6653-65. Epub 2015 Aug 26.

U.O. Multidisciplinare di Patologia Mammaria, U.S. Terapia Molecolare e Farmacogenomica, AZ. Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy.

View Article and Find Full Text PDF
September 2015

Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?

Oncoscience 2015 5;2(6):567-9. Epub 2015 Jun 5.

U.S. Terapia Molecolare e Farmacogenomica, AO Azienda Istituti Ospitalieri di Cremona, Cremona, Italy.

View Article and Find Full Text PDF
August 2015

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).

J Natl Cancer Inst Monogr 2015 May;2015(51):90-6

Medical Oncology Unit (VA, ABe), University of Brescia, and Breast Unit (RP, LV, ELS) Spedali Civili Hospital, Brescia, Italy; U.O. Multidisciplinare di Patologia Mammaria, S.S. Terapia Molecolare e Farmacogenomica, AZ. Istituti Ospitalieri di Cremona, Cremona, Italy (DG, AR, MRC, LD, ABo); Departments of Radiation Oncology (TB) and Pathology (FS), University of Texas MD Anderson Cancer Center, Houston, TX; Department of Medical Oncology and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA (MC); Division of Experimental Therapeutics, Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy (GC); Biomarkers Unit, Department of Experimental Oncology and Molecular Medicine (MGD), and Medical Oncology Unit (SDC), Fondazione IRCCS - Istituto Nazionale Tumori, Milan, Italy (MGD); Academic Department of Biochemistry, Biochemical Endocrinology (MD), Department of Surgery, Breast Unit (PB), and The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research and Breast Unit (MD, GS), Royal Marsden Hospital, London, UK; Department of Pathology, Melbourne University, Parkville, Australia (SF); Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK (ALH); Mount Vernon Cancer Centre, London, UK (AM); Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT (CH); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Division of Medical Oncology, Department of Hemato-oncology, IRCCS Policlinico 'San Matteo' Foundation, Pavia, Italy (PP); Dipartimento Medicina di Laboratorio, SC Anatomia ed Istocitopatologia Diagnostica e di Screening, A.O.U. Città della Salute e della Scienza di Torino, Università di Torino, Turin, Italy (AS); N. N. Petrov Research Institute of Oncology, St. Petersburg, Russia (VS); German Breast Group & University of Frankfurt, Neu-Isenburg, Germany (GvM); The Russell H. Morgan Department of Radiology

View Article and Find Full Text PDF
May 2015

RNA Disruption and Drug Response in Breast Cancer Primary Systemic Therapy.

J Natl Cancer Inst Monogr 2015 May;2015(51):76-80

Rna Diagnostics Inc, Toronto, ON, Canada (KP, LP, AP); Department of Laboratory Medicine and Pathobiology and Department of Surgery, University of Toronto, Toronto, ON, Canada (KP, MT); Unita di Patologia Mammaria, Breasteast Unit, Azienda Ospedaliera Istituti Ospitaieri di Cremona, Cremona, Italy (DG, AB, MRC); Advanced Medical Research Institute of Canada, Sudbury, ON, Canada (BG, AP); Laurentian University, Sudbury ON, Canada (AP); Odette Cancer Centre, Sunnybrook Hospital, Toronto, ON, Canada (MT).

View Article and Find Full Text PDF
May 2015

Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical Response.

J Natl Cancer Inst Monogr 2015 May;2015(51):64-6

U.O. Multidisciplinare di Patologia Mammaria/ US Terapia Molecolare (DG, MRC, LZ, GB, MF, FB, MEV, MM, CS, MA, SA, GA, ABo), and Anatomia Patologica (GF, RB), Azienda Istituti Ospitalieri di Cremona, Cremona, Italy; Oncologia Medica, Università di Brescia, Spedali Civili di Brescia, Brescia, Italy (ABe, GB); Weatherall Molecular Oncology Laboratories, Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK (ALH); Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Australia (SBF).

View Article and Find Full Text PDF
May 2015

Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?

J Natl Cancer Inst Monogr 2015 May;2015(51):32-5

U.O. Multidisciplinare di Patologia Mammaria, U.S Terapia Molecolare e Farmacogenomica, A.O. Istituti Ospitalieri di Cremona, Cremona, Italy (DG, MA, CS, MMi, MRC, LZ, MF, FB, MMa, ABo); U.O. Oncologia Medica, Spedali Civili si Brescia, Brescia, Italy (VA, ES, ABe); Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia Medical School, Brescia, Italy (FB, SS).

View Article and Find Full Text PDF
May 2015

Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.

Tumour Biol 2014 Sep 23;35(9):8461-70. Epub 2014 Jul 23.

Pharmacogenomics and Molecular Therapy, A.O. Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy.

View Article and Find Full Text PDF
September 2014